# Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome

> **NCT00671515** · PHASE2 · COMPLETED · sponsor: **Joseph Calabrese, MD** · enrollment: 23 (actual)

## Conditions studied

- Depressive Disorder, Major
- Metabolic Syndrome X

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT00671515
- **Lead sponsor:** Joseph Calabrese, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-08
- **Final completion:** 2011-11
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2017-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00671515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00671515, "Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00671515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*